Trademark: 88138274
Status Date
Monday, June 6, 2022
Filing Date
Monday, October 1, 2018
Published for Opposition
Tuesday, March 5, 2019
Abandoned Date
Monday, June 6, 2022
5 Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism
Jun 6, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 6, 2022
Abandonment - No Use Statement Filed
Nov 3, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 2, 2021
Sou Extension 5 Granted
Oct 28, 2021
Sou Extension 5 Filed
Oct 28, 2021
Teas Extension Received
May 1, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 29, 2021
Sou Extension 4 Granted
Apr 29, 2021
Sou Extension 4 Filed
Apr 29, 2021
Teas Extension Received
Oct 8, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 6, 2020
Sou Extension 3 Granted
Oct 6, 2020
Sou Extension 3 Filed
Oct 6, 2020
Teas Extension Received
May 2, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 30, 2020
Sou Extension 2 Granted
Apr 30, 2020
Sou Extension 2 Filed
Apr 30, 2020
Teas Extension Received
Jan 14, 2020
Notice Of Approval Of Extension Request E-Mailed
Jan 13, 2020
Sou Extension 1 Granted
Oct 30, 2019
Sou Extension 1 Filed
Jan 13, 2020
Case Assigned To Intent To Use Paralegal
Dec 4, 2019
Notice Of Revival - E-Mailed
Dec 3, 2019
Extension Received With Teas Petition
Dec 3, 2019
Petition To Revive-Granted
Dec 3, 2019
Teas Petition To Revive Received
Dec 2, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 2, 2019
Abandonment - No Use Statement Filed
Apr 30, 2019
Noa E-Mailed - Sou Required From Applicant
Mar 5, 2019
Official Gazette Publication Confirmation E-Mailed
Mar 5, 2019
Published For Opposition
Feb 13, 2019
Notification Of Notice Of Publication E-Mailed
Jan 18, 2019
Approved For Pub - Principal Register
Jan 11, 2019
Assigned To Examiner
Oct 9, 2018
New Application Office Supplied Data Entered In Tram
Oct 4, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
